DocGo Inc. (NASDAQ:DCGO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of DocGo Inc. (NASDAQ:DCGO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six research firms that are currently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $3.56.

Several brokerages recently commented on DCGO. Needham & Company LLC dropped their price target on shares of DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a research report on Friday, May 9th. BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Finally, Canaccord Genuity Group reaffirmed a "hold" rating and set a $1.45 price target (down previously from $5.00) on shares of DocGo in a research report on Monday, May 12th.

DocGo Stock Performance

Shares of DCGO opened at $1.57 on Thursday. The company has a market capitalization of $160.11 million, a price-to-earnings ratio of -78.50 and a beta of 0.97. The company's 50 day simple moving average is $1.67 and its 200 day simple moving average is $3.03. DocGo has a 1 year low of $1.23 and a 1 year high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The firm had revenue of $96.03 million for the quarter, compared to analysts' expectations of $104.25 million. DocGo had a negative net margin of 0.12% and a positive return on equity of 2.52%. Equities analysts expect that DocGo will post 0.25 EPS for the current fiscal year.

Hedge Funds Weigh In On DocGo

Several large investors have recently modified their holdings of the stock. Invesco Ltd. lifted its position in shares of DocGo by 1.3% during the fourth quarter. Invesco Ltd. now owns 177,953 shares of the company's stock worth $755,000 after purchasing an additional 2,312 shares during the last quarter. Summit Investment Advisors Inc. raised its stake in DocGo by 38.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock worth $45,000 after acquiring an additional 2,968 shares during the period. Rhumbline Advisers raised its stake in DocGo by 4.5% during the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company's stock worth $605,000 after acquiring an additional 6,204 shares during the period. Victory Capital Management Inc. raised its stake in DocGo by 12.3% during the fourth quarter. Victory Capital Management Inc. now owns 57,649 shares of the company's stock worth $244,000 after acquiring an additional 6,300 shares during the period. Finally, MetLife Investment Management LLC raised its stake in DocGo by 12.1% during the fourth quarter. MetLife Investment Management LLC now owns 60,245 shares of the company's stock worth $255,000 after acquiring an additional 6,517 shares during the period. Institutional investors own 56.44% of the company's stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.